Richard R P Warner

Summary

Publications

  1. ncbi request reprint Enteroendocrine tumors other than carcinoid: a review of clinically significant advances
    Richard R P Warner
    Gastrointestinal Division, Department of Medicine, The Mount Sinai School of Medicine, New York, New York 10128, USA
    Gastroenterology 128:1668-84. 2005
  2. doi request reprint Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors
    Thomas Curran
    Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Pancreas 40:1253-7. 2011
  3. doi request reprint The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix
    Eric Liu
    Division of General Surgery, Department of Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Am J Surg 202:400-3. 2011
  4. doi request reprint Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature
    Steven Naymagon
    Department of Medicine, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
    Dig Dis Sci 55:2450-8. 2010
  5. ncbi request reprint A carcinoid tumor associated with chylous ascites and elevated tumor markers
    Richard R P Warner
    Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Int J Colorectal Dis 17:156-60. 2002
  6. doi request reprint The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids
    Eric Liu
    Division of General Surgery, Department of Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Surg Oncol 102:338-41. 2010
  7. ncbi request reprint Surgery in malignant pancreatic neuroendocrine tumors
    Scott Q Nguyen
    Department of Surgery, Division of General Surgery, The Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    J Surg Oncol 96:397-403. 2007
  8. doi request reprint The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study
    Sunil Amin
    Department of Internal Medicine, Mount Sinai School of Medicine, 5 East 98th Street, 11th Floor, New York, New York 10029, USA
    Endocr Relat Cancer 19:381-7. 2012
  9. doi request reprint Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome
    Mark A Hoffman
    Division of Hematology Oncology, Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    J Vasc Interv Radiol 19:1099-102. 2008
  10. doi request reprint Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors
    Richard R P Warner
    Division of Gastroenterology, Department of Medicine, Center for Carcinoid and Neuroendocrine Tumors, New York, NY 10029, USA
    Pancreas 40:622-6. 2011

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Enteroendocrine tumors other than carcinoid: a review of clinically significant advances
    Richard R P Warner
    Gastrointestinal Division, Department of Medicine, The Mount Sinai School of Medicine, New York, New York 10128, USA
    Gastroenterology 128:1668-84. 2005
    ..Advances in these various therapies are reviewed and the beneficial emergence of global self-help patient support groups is noted...
  2. doi request reprint Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors
    Thomas Curran
    Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Pancreas 40:1253-7. 2011
    ..Neuroendocrine tumors demonstrate heterogeneous behavior based on the site of origin and histology. This study aimed to delineate prognostic clinicopathologic features in patients with metastatic midgut carcinoid...
  3. doi request reprint The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix
    Eric Liu
    Division of General Surgery, Department of Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Am J Surg 202:400-3. 2011
    ..The aim of this study was to examine the role of Ki-67, a cellular proliferation marker, in the prognosis of goblet cell appendiceal carcinoid tumor...
  4. doi request reprint Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature
    Steven Naymagon
    Department of Medicine, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
    Dig Dis Sci 55:2450-8. 2010
    ..Despite the relatively high precision of this modality, numerous adverse effects have been recognized. One particularly untoward complication is the development of severe gastroduodenal ulceration...
  5. ncbi request reprint A carcinoid tumor associated with chylous ascites and elevated tumor markers
    Richard R P Warner
    Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Int J Colorectal Dis 17:156-60. 2002
    ..The patient's clinical course and beneficial response to chemotherapy is also discussed and previous similar cases reported in the English-language literature are reviewed...
  6. doi request reprint The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids
    Eric Liu
    Division of General Surgery, Department of Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Surg Oncol 102:338-41. 2010
    ..To elucidate the correlation of Ki-67 with tumor biology and survival in appendiceal carcinoid tumors...
  7. ncbi request reprint Surgery in malignant pancreatic neuroendocrine tumors
    Scott Q Nguyen
    Department of Surgery, Division of General Surgery, The Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    J Surg Oncol 96:397-403. 2007
    ..The purpose of this study is to review a series of patients with these tumors and investigate the role of surgery in the treatment...
  8. doi request reprint The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study
    Sunil Amin
    Department of Internal Medicine, Mount Sinai School of Medicine, 5 East 98th Street, 11th Floor, New York, New York 10029, USA
    Endocr Relat Cancer 19:381-7. 2012
    ..When these primaries occur prior to (but not after) the SIC diagnosis, the prognosis is worse than with an initial SIC. The type of malignancies associated with SICs may guide future screening efforts...
  9. doi request reprint Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome
    Mark A Hoffman
    Division of Hematology Oncology, Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    J Vasc Interv Radiol 19:1099-102. 2008
  10. doi request reprint Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors
    Richard R P Warner
    Division of Gastroenterology, Department of Medicine, Center for Carcinoid and Neuroendocrine Tumors, New York, NY 10029, USA
    Pancreas 40:622-6. 2011
    ....
  11. doi request reprint Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors
    Junko Ozao-Choy
    Department of Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Surg Res 162:22-5. 2010
    ....
  12. doi request reprint The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum
    Lowell B Anthony
    Department of Medicine, Louisiana State University Medical Center, New Orleans, LA, USA
    Pancreas 39:767-74. 2010
    ..Colorectal NETs are generally not associated with a hormonal syndrome such as flushing or diarrhea. A multidisciplinary approach is recommended in diagnosing and managing hindgut NETs...
  13. doi request reprint Serum pancreastatin: the next predictive neuroendocrine tumor marker
    Sapna Rustagi
    Department of Surgery, The Mount Sinai Hospital New York, New York, NY 10029, USA
    J Surg Oncol 108:126-8. 2013
    ..Pancreastatin is a derived peptide of chromogranin A (CgA). Pancreastatin has the potential to be a diagnostic and predictive tumor marker in detecting NETs...
  14. ncbi request reprint Management of goblet cell carcinoid
    John C Byrn
    Department of Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Surg Oncol 94:396-402. 2006
    ..Sixteen new cases of gastrointestinal goblet cell carcinoid were reviewed to describe their presentation, treatment, and outcome...
  15. ncbi request reprint Presentation, treatment, and outcome of type 1 gastric carcinoid tumors
    Gregory F Dakin
    Department of Surgery, Weill Medical College of Cornell University, New York, NY, USA
    J Surg Oncol 93:368-72. 2006
    ..The aim of this study was to review the presentation, treatment, and outcome of patients with Type 1 gastric carcinoid tumors...
  16. ncbi request reprint Testicular metastasis of primary cecal carcinoid tumor
    Guang Qian Xiao
    Departments of Pathology, Urology, and Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Ann Diagn Pathol 8:102-7. 2004
    ..However, he developed a secondary testicular metastasis. He has otherwise remained well, without evidence of metastases elsewhere on imaging studies...
  17. ncbi request reprint Biochemical assessment of niacin deficiency among carcinoid cancer patients
    Girish M Shah
    Laboratory for Skin Cancer Research, CHUL Research Center CHUQ, Faculty of Medicine, Laval University, Sainte Foy, Quebec, Canada
    Am J Gastroenterol 100:2307-14. 2005
    ....
  18. doi request reprint Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients
    Andrew S Kennedy
    Wake Radiology Oncology, Cary, NC 27511, USA
    Am J Clin Oncol 31:271-9. 2008
    ..The use of 90Y-microspheres to treat unresectable liver metastases originating from a variety of neuroendocrine tumors was reviewed...